Search research articles
Contact Us
Filters
Showing results (91-100 of 136) with videos related to
Page
of 14
Sort By:
Diagnostic Pathology
|
April 30, 2025
CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases
Laura González-Guerrero, Helena Castellet, Clara Martínez, et al.
Oncotarget
|
June 10, 2015
Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile
Lourdes Martín-Martín, Antonio López, Belén Vidriales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2008
Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication
Francesc Bosch, Ana Ferrer, Neus Villamor, et al.
International Journal of Cancer
|
November 24, 2018
Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia
Eriong Lee-Vergés, Bola S Hanna, Haniyeh Yazdanparast, et al.
Cells
|
November 27, 2024
Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia
Juan A Piñeyroa, Irene López-Oreja, Ferran Nadeu, et al.
British Journal of Haematology
|
December 6, 2018
Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era
Alfredo Rivas-Delgado, Laura Magnano, Miriam Moreno-Velázquez, et al.
Hematological Oncology
|
May 25, 2022
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia
Juan A Piñeyroa, Laura Magnano, Andrea Rivero, et al.
The American Journal of Surgical Pathology
|
October 2, 2015
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease
Daniel Martinez, Alba Navarro, Alejandra Martinez-Trillos, et al.
Blood
|
September 6, 2018
Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia
Gabriel Bretones, Miguel G Álvarez, Javier R Arango, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2009
Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia
Francesc Bosch, Pau Abrisqueta, Neus Villamor, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 136) with videos related to
Sort By:
Page
of 14
Diagnostic Pathology
|
April 30, 2025
CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases
Laura González-Guerrero, Helena Castellet, Clara Martínez, et al.
Oncotarget
|
June 10, 2015
Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile
Lourdes Martín-Martín, Antonio López, Belén Vidriales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2008
Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication
Francesc Bosch, Ana Ferrer, Neus Villamor, et al.
International Journal of Cancer
|
November 24, 2018
Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia
Eriong Lee-Vergés, Bola S Hanna, Haniyeh Yazdanparast, et al.
Cells
|
November 27, 2024
Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia
Juan A Piñeyroa, Irene López-Oreja, Ferran Nadeu, et al.
British Journal of Haematology
|
December 6, 2018
Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era
Alfredo Rivas-Delgado, Laura Magnano, Miriam Moreno-Velázquez, et al.
Hematological Oncology
|
May 25, 2022
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia
Juan A Piñeyroa, Laura Magnano, Andrea Rivero, et al.
The American Journal of Surgical Pathology
|
October 2, 2015
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease
Daniel Martinez, Alba Navarro, Alejandra Martinez-Trillos, et al.
Blood
|
September 6, 2018
Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia
Gabriel Bretones, Miguel G Álvarez, Javier R Arango, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2009
Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia
Francesc Bosch, Pau Abrisqueta, Neus Villamor, et al.
Page
of 14